Xylo Technologies (Xylo Technologies) Change In Receivables : $8.92 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Xylo Technologies Change In Receivables?

Xylo Technologies's change in receivables for the quarter that ended in Dec. 2023 was $6.32 Mil. It means Xylo Technologies's Accounts Receivable declined by $6.32 Mil from Jun. 2023 to Dec. 2023 .

Xylo Technologies's change in receivables for the fiscal year that ended in Dec. 2023 was $8.92 Mil. It means Xylo Technologies's Accounts Receivable declined by $8.92 Mil from Dec. 2022 to Dec. 2023 .

Xylo Technologies's Accounts Receivable for the quarter that ended in Dec. 2023 was $12.32 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Xylo Technologies's Days Sales Outstanding for the six months ended in Dec. 2023 was 58.65.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Xylo Technologies's liquidation value for the six months ended in Dec. 2023 was $-8.49 Mil.

Xylo Technologies Change In Receivables Historical Data

The historical data trend for Xylo Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xylo Technologies Change In Receivables Chart

Xylo Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-0.07

-0.01

-7.96

8.92

Xylo Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-0.14	-2.77	-5.19	2.60	6.32

Xylo Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $8.92 Mil.

Xylo Technologies (NAS:XYLO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Xylo Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	12.32	/	38.339	*	91
=	58.65

2. In Ben Graham's calculation of liquidation value, Xylo Technologies's accounts receivable are only considered to be worth 75% of book value:

Xylo Technologies's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	12.536	-	31.461	+	0.75 * 12.32	+	0.5 * 2.386
=	-8.49

Xylo Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Xylo Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Xylo Technologies (Xylo Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xylo Technologies Ltd (NAS:XYLO) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

2QM0:Germany

Address

10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072

Website

https://www.medigus.com

Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.